Home
About Humanigen
Our Programs
Benznidazole
Lenzilumab
Ifabotuzumab
Investors
Overview
Press Releases / Events
Company Information
SEC Filings
Stock Data
Corporate Governance
Highlights
Contact Us
Show Menu
Press Releases
Investors
Overview
Press Releases / Events
Press Releases
IR Calendar
Email Alerts
Company Info
Profile
Presentations
Leadership
Contacts
FAQ
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Stock Data
Quote
Charts
Historical Data
Governance
Board of Directors
Board Committees
Governance Documents
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
Press Releases / Events
Press Releases
IR Calendar
Email Alerts
Humanigen CEO Receives PharmaVOICE 100 Red Jacket Award
Aug 11, 2017
Humanigen Announces Completion of Benznidazole Bioavailability Study
Aug 8, 2017
Humanigen, Inc. Is Effective Today
Aug 7, 2017
View Archived Press Releases
